Results 131 to 140 of about 47,011 (239)

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. [PDF]

Front Immunol
Zhu C, Yang J, Sheng Y, Fang M.
europepmc   +1 more source

Trends in Hepatitis B, Hepatitis C, and HIV Seroprevalence in the Netherlands: Insights From Two Decades of Nationwide PIENTER Serosurveys

Journal of Viral Hepatitis, Volume 33, Issue 8, August 2026.
ABSTRACT Hepatitis B (HBV), hepatitis C (HCV), and HIV remain public health challenges despite effective treatments and preventive options. Infections are often asymptomatic, leading to undiagnosed cases, onward transmission, and preventable morbidity and mortality.
Christine G. J. I. van Straten, Birgit H. B. van Benthem, Fiona R. M. van der Klis, Gaby Smits, Eric R. A. Vos, Tom Woudenberg, Marc van der Valk, Eline L. M. Op de Coul   +7 more
wiley   +1 more source

Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapy. [PDF]

Hepatol Commun
Shigeno S, Kodama T, Murai K, Sometani E, Yasuda K, Tahata Y, Nishio A, Tanaka S, Miyazaki M, Ohkawa K, Kakita N, Tawara S, Yakushijin T, Hikita H, Toyoda H, Takehara T.   +15 more
europepmc   +1 more source

An Exploratory Cost‐Utility Analysis of Screening and Treating Immigrants in Canada for Hepatitis D

Journal of Viral Hepatitis, Volume 33, Issue 8, August 2026.
ABSTRACT Hepatitis D is common among immigrants in Canada, who account for approximately 23% of the population and tend to originate from high‐endemic countries. Mortality rates are notably high among those with chronic infections, and immigrants are less likely to engage in screening and treatment services.
Jiahao Zhao, Diedron Lewis, John‐Michael Gamble, Zahid A. Butt, William W. L. Wong   +4 more
wiley   +1 more source

Clinical significance and mutation analysis of HBsAg and Anti-HBs coexistence in Chronic Hepatitis B. [PDF]

Virus Res
Zhang S, Lai X, Dai H, Li X, Li X, Liu F, Zhou T, Wei J.   +7 more
europepmc   +1 more source

Prevention of HBV Mother‐To‐Child Transmission (MTCT) Using Targeted HBV Birth Dose, and Treatment of High Viral Load Pregnant Women in Uganda

Journal of Viral Hepatitis, Volume 33, Issue 8, August 2026.
ABSTRACT Hepatitis B virus (HBV) mother‐to‐child transmission (MTCT) remains a major challenge in Uganda, where 43% of births occur at home, and access to timely birth dose (BD) vaccination is limited. We evaluated the impact of combining universal three‐dose (3D) infant vaccination, targeted BD vaccination, and maternal antiviral treatment for high ...
Samantha Hall, Ponsiano Ocama, Danielle Leavelle, Julius Kiwanuka, Brian Lwanga, Joan Nankya‐Mutyoba, Calvin Q. Pan, Christine Namulindwa, Viola Kasone, Rachel Beyagira, Homie Razavi   +10 more
wiley   +1 more source

Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring. [PDF]

Liver Int
Matar R, Roudot-Thoraval F, Ortonne V, Garrigou O, Soulier A, Cappy P, Candotti D, Ingiliz P, Pawlotsky JM, Leroy V, Chevaliez S.   +10 more
europepmc   +1 more source

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu, Margarita Papatheodoridi, Habiba Kamal Khodir, Sabela Lens, Elisabetta Degasperi, Speranta Iacob, Liliana Gheorghe, Katja Steppich, Florin Alexandru Caruntu, Pietro Lampertico, Soo Aleman, Heiner Wedemeyer   +11 more
wiley   +1 more source

Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity. [PDF]

Viruses
D'Anna S, Piermatteo L, Magnapera A, Grossi I, Tramontozzi C, Olivero A, Duca L, Torre G, Teti E, Di Lorenzo A, Malagnino V, Iannetta M, Grelli S, Paba P, Bertoli A, Ceccherini-Silberstein F, Baiocchi L, Francioso S, Lenci I, Milella M, Saracino A, Ciancio A, Brancaccio G, Sarmati L, Lampertico P, Rizzetto M, Caviglia GP, Salpini R, Svicher V.   +28 more
europepmc   +1 more source

High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims Chronic hepatitis B virus (HBV) infection is endemic in Uzbekistan. Previous data showed a high prevalence of anti‐hepatitis D virus (HDV) antibodies in HBsAg‐positive individuals. Limited data are available on disease severity, treatment availability and hepatocellular carcinoma (HCC) prevalence in patients with chronic ...
Malika E. Khodjaeva, Aziza S. Khikmatullaeva, Nargiz S. Ibadullaeva, Gulnara K. Khudaykulova, Munisa M. Ilyasova, Kamila U. Eshbayeva, Dildorakhon N. Abdurakhmanova, Helenie Kefalakes, Petra Huber, Michael J. Gebel, Erkin I. Musabaev, Heiner Wedemeyer, Lisa Sandmann   +12 more
wiley   +1 more source